Market Research Future Predicts the Global Healthcare Cold Chain Logistics Market to Attain a 7.54% CAGR During 2017-2023


Healthcare Cold Chain Logistics Market Size, Share, Growth, Global Analysis, Trends Information by Product type (Biopharmaceuticals, Vaccines, Clinical Trial Materials and Others), Services (Storage, Transportation, Packaging and Others), Storage Techniques (Electrical refrigeration, Dry Ice, Gel Packs, Liquid nitrogen and Others), By Region (North America, Europe, Asia Pacific, The Middle East & Africa (MEA) and Latin America) – Global Forecast by 2023
Market Synopsis:
The pharmaceutical industry is expanding at a substantial rate creating immense opportunity for the healthcare cold chain logistics market to proliferate. Personalized drugs and other thermolabile pharmaceutical products like vaccination requires uninterrupted refrigeration to protect from fluctuating temperature conditions during transportation. Cold chain logistics plays a pivotal role in maintaining the potency of those healthcare products during transportation until administered to the targeted end users.
Demand for cold chain logistics in the healthcare sector is increasing with time and the global Healthcare Cold Chain Logistics Market is expected to grow with a 7.54% CAGR during the forecast period 2018-2023 predicts Market Research Future (MRFR).
The rise in number of clinical research cases is likely to shoot up the growth curve of the market. Although cold chain logistics is contributing largely to safe delivery and distribution of temperature-sensitive products which is the major factor propelling the global healthcare cold chain logistics market there are challenges which are likely to halt the market growth. Loopholes in regulatory standards for healthcare cold chain logistics and improper management disrupting the flow of logistics operations are anticipated to interfere the market expansion. 
Key players:
·         AmerisourceBergen Corporation
·         American Airlines
·         DB Schenker
·         FedEx
·         Marken
·         Cavalier Logistics
·         KUEHNE + NAGEL
·         DHL international GmbH
Segmental Analysis:
·         The MRFR report includes a detailed segmental analysis of the market based on product type, storage techniques, end user and services.
·         Based on product type, the healthcare cold chain logistics market is segmented into clinical trial materials, vaccines, biopharmaceuticals, and others.
·         Based on product type, the market has been segmented into clinical trial materials, vaccines, biopharmaceuticals, and others.
·         Based on services, the market has been segmented into packaging, transportation, storage and others
·         Based on storage techniques, the market has been segmented into liquid nitrogen, electrical refrigeration, gel packs, dry ice and others.
·         Based on end user, the market has been segmented into research institutes, hospitals and clinics, biopharmaceutical companies, and others. The biopharmaceutical segment is expected to grow with the highest CAGR during the forthcoming period.
Regional Analysis:
Based on region the market has been segmented into North America, Asia Pacific (APAC), Europe and the Middles East and Africa (MEA). North America is anticipated to augment the market growth owing to increasing advancements in the pharmaceutical sector and numerous service providers in the region. Followed by Latin America the Asia Pacific and European regions to experience market expansion followed by Latin America.
Industry Update
April 2019: Tata Motors recently invested in a pharmaceutical cold chain specialist, Kool-ex, is experiencing substantial growth. Owing to the increasing demand for cold chain logistics in the pharma sector, Tata Motors is planning to invest Rs 140 crore in the next two years to double its fleet to 800 reefer trucks

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more